PGR and breast carcinoma: Triple negative breast cancer (TNBC), regarded as a heterogeneous and aggressive breast cancer subtype and characterized by impaired expression of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2, represents 10%–25% of breast cancers types and thus is strongly associated with poorer prognosis (2, 3).